- Investing Ideas
- /
- South Korean Healthcare Undervalued based on future growth
South Korean Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
Dentium
Market Cap: ₩501.9b
Manufactures and sells dental medical instrument worldwide.
A145720
₩58,200.00
7D
3.4%
1Y
-22.7%
T&L
Market Cap: ₩435.9b
Engages in the manufacture and sale of medical and polymer material products in South Korea.
A340570
₩54,000.00
7D
2.1%
1Y
-18.8%
InBodyLtd
Market Cap: ₩335.3b
Provides body composition analysis solutions worldwide.
A041830
₩27,500.00
7D
1.3%
1Y
19.6%
Suheung
Market Cap: ₩295.8b
Engages in produces and sells hard and soft capsules.
A008490
₩26,600.00
7D
-8.1%
1Y
62.7%
Vieworks
Market Cap: ₩182.6b
Develops, manufactures, and sells imaging systems and solutions.
A100120
₩20,350.00
7D
-0.5%
1Y
-22.0%
Meta Biomed
Market Cap: ₩168.2b
Engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa.
A059210
₩6,320.00
7D
-1.3%
1Y
58.2%
OSTEONIC
Market Cap: ₩161.5b
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems.
A226400
₩8,050.00
7D
0.4%
1Y
54.5%